ZEVRA THERAPEUTICS, INC. — Director's Dealing 2019

Sep 16, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: KEMPHARM, INC (KMPH)
CIK: 0001434647
Period of Report: 2019-09-16

Reporting Person: Clifton R. LaDuane (CFO, Secretary & Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-16	Common Stock	P	100	$0.86	Acquired	4200	Direct
2019-09-16	Common Stock	P	4900	$0.8856	Acquired	9100	Direct